Your browser doesn't support javascript.
loading
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
Rapeport, Garth; Smith, Emma; Gilbert, Anthony; Catchpole, Andrew; McShane, Helen; Chiu, Christopher.
Afiliación
  • Rapeport G; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
  • Smith E; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
  • Gilbert A; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
  • Catchpole A; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
  • McShane H; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
  • Chiu C; From the National Heart and Lung Institute (G.R., E.S.) and the Department of Infectious Disease (C.C.), Imperial College London; the U.K. Vaccines Taskforce (A.G.); and hVIVO Services (A.C.) - all in London; and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom (H.M.).
N Engl J Med ; 385(11): 961-964, 2021 Sep 09.
Article en En | MEDLINE | ID: mdl-34289273
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ensayos Clínicos como Asunto / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Experimentación Humana Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ensayos Clínicos como Asunto / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Experimentación Humana Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article